Fresenius Kabi, an operating company of Fresenius, announced that the Centers for Medicare and Medicaid Services issued a permanent, product-specific billing code for Otulfi (ustekinumab-aauz). Under ...
The CMS could issue a rule this year requiring healthcare companies to share more information on drug costs, as the Trump administration continues to push for more price transparency in the sector, ...
CMS is launching a pilot program aimed at lowering prescription drug costs in Medicaid by aligning prices with those paid in other developed countries. The program is set to begin in January. “CMS is ...
CMS recently announced the next 15 drugs that will be subject to price negotiations under the Inflation Reduction Act of 2022 (IRA). These are negotiations in name only because CMS can levy penalties ...
While the 15 medications selected for the latest round of the federal government’s drug price negotiation program will face steep cuts in what Medicare will pay, the financial impact to pharmaceutical ...
The Centers for Medicare & Medicaid Services (CMS) today announced a landmark initiative, the GENErating cost Reductions fOr U.S. (GENEROUS) Medicaid Model, aimed at significantly lowering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results